These results, together with a previous report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assistance the notion of concentrating on ACKR3 as a singular technique to modulate the opioid technique, which could open new therapeutic avenues for o